Novel Therapeutics for Anthracycline Induced Cardiotoxicity

Novel Therapeutics for Anthracycline Induced Cardiotoxicity

Anthracyclines remain an essential component of the treatment of many hematologic and solid organ malignancies, but has important implications on cardiovascular disease. Anthracycline induced cardiotoxicity (AIC) ranges from asymptomatic LV dysfunction to highly morbid end- stage heart failure. As c...

Full description

Bibliographic Details
Main Authors: Jacqueline T. Vuong, Ashley F. Stein-Merlob, Richard K. Cheng, Eric H. Yang
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-04-01
Series:Frontiers in Cardiovascular Medicine
Subjects:
cardio-oncology
anthracyclines
cardiotoxicity
cardiomyopathy
heart failure
Online Access:https://www.frontiersin.org/articles/10.3389/fcvm.2022.863314/full

Internet

https://www.frontiersin.org/articles/10.3389/fcvm.2022.863314/full

Similar Items